Author: Müller-Redetzky, Holger C.; Lienau, Jasmin; Witzenrath, Martin
Title: The Lung Endothelial Barrier in Acute Inflammation Cord-id: ow3ulny0 Document date: 2015_8_28
ID: ow3ulny0
Snippet: In the lungs, alveolar endo- and epithelial cells and their merged basal laminae form a delicate membrane, which allows rapid and effective gas exchange between alveolar and vascular lumen and, at the same time, provides a barrier to protect against inhaled particles and pathogens. Following infectious or sterile inflammatory conditions, strictly controlled endothelial leakiness is required for leukocyte transmigration. However, increased permeability caused by host-dependent inflammatory mechan
Document: In the lungs, alveolar endo- and epithelial cells and their merged basal laminae form a delicate membrane, which allows rapid and effective gas exchange between alveolar and vascular lumen and, at the same time, provides a barrier to protect against inhaled particles and pathogens. Following infectious or sterile inflammatory conditions, strictly controlled endothelial leakiness is required for leukocyte transmigration. However, increased permeability caused by host-dependent inflammatory mechanisms or pathogen-induced endothelial injury may lead to uncontrolled protein-rich fluid extravasation, lung edema and finally acute respiratory distress syndrome (ARDS), which still carries an unacceptably high mortality rate. This chapter gives an overview of major mechanisms underlying pulmonary endothelial barrier regulation and disruption, focusing on the role of specific cell populations, complement and coagulation systems and mediators including angiopoietins, sphingolipids, adrenomedullin, as well as reactive oxygen and nitrogen species in the regulation of pulmonary vascular permeability. Further, current therapeutic strategies targeting the pulmonary endothelial barrier to improve barrier function are discussed.
Search related documents:
Co phrase search for related documents- acute inflammation and adhesion molecule: 1, 2, 3, 4, 5, 6
- acute inflammation and adjuvant therapy: 1
- acute inflammation and low mortality: 1, 2, 3
- acute inflammation and lps challenge: 1, 2
- acute inflammation and lps infusion: 1, 2
- acute inflammation and lps injection: 1, 2, 3, 4, 5, 6
- acute inflammation and lps stimulation: 1, 2, 3, 4
- acute inflammation and lung edema: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute inflammation and lung endothelial: 1, 2, 3, 4, 5, 6, 7
- acute inflammation and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
- acute inflammation and lung inflammation reduced permeability: 1
- acute inflammation and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acute inflammation and lung injury attenuate: 1, 2
- acute inflammation and lung injury contribute: 1, 2
- acute inflammation and lung injury development: 1, 2, 3, 4
- acute inflammation and lung injury pathogenesis: 1, 2
- acute inflammation and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- acute inflammation and lung vascular: 1, 2, 3, 4, 5, 6, 7
- acute inflammation and macrophage receptor: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date